跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,606 条关于
“YuanBio Venture Capital”
全部
5,606
临床试验
1,648
药物
79
机构
403
资讯
3,476
去年
AusperBio Secures $50 Million Series B+ Funding to Advance Hepatitis B Functional Cure Candidate AHB-137
9个月前
Allink Biotherapeutics Raises $47M to Advance Two ADC Programs in Global Phase I Trials
去年
Allink Biotherapeutics Secures $42 Million in Series A Funding to Advance Bispecific Antibody and ADC Pipeline
上个月
CORE Biomedicine Secures $21 Million Series A and Eisai Licensing Deal to Advance Lineage-Based Precision Oncology Pipeline
21天前
AusperBio Completes $120 Million Series C to Advance AHB-137 Toward Commercialization in Chronic Hepatitis B
6个月前
Excalipoint Therapeutics Secures $68.7 Million in Seed Funding to Advance Next-Generation T-Cell Engager Pipeline
上个月
Beyang Therapeutics Closes Oversubscribed $30 Million Series A to Advance AI-Driven Drug Pipeline
2个月前
Venture Capital Surge Propels Catalonia's Life Sciences Sector to Record Investment Heights
去年
Bristol Myers Squibb and Bain Capital Launch $300M Immunology Drug Development Venture
9个月前
FDA Proposes Direct Contracting Model with Venture Capital Firms to Accelerate Healthcare Innovation
第 1 页,共 348 页
上一页
下一页